Susquehanna International Group (Ireland)’s Enlivex Therapeutics ENLV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-12,326
| Closed | -$19.5K | – | 67 |
|
|
2023
Q3 | $19.5K | Sell |
12,326
-2,765
| -18% | -$4.37K | ﹤0.01% | 59 |
|
|
2023
Q2 | $39.7K | Sell |
15,091
-2,775
| -16% | -$7.3K | 0.03% | 55 |
|
|
2023
Q1 | $65K | Sell |
17,866
-1,021
| -5% | -$3.72K | 0.04% | 51 |
|
|
2022
Q4 | $72.1K | Sell |
18,887
-1,412
| -7% | -$5.39K | 0.03% | 45 |
|
|
2022
Q3 | $85K | Sell |
20,299
-1,703
| -8% | -$7.13K | 0.03% | 53 |
|
|
2022
Q2 | $98K | Sell |
22,002
-470
| -2% | -$2.09K | 0.02% | 78 |
|
|
2022
Q1 | $126K | Buy |
+22,472
| New | +$126K | 0.04% | 59 |
|